Possibility of brigatinib‐based therapy, or chemotherapy plus anti‐angiogenic treatment after resistance of osimertinib harboring EGFR T790M‐cis‐C797S mutations in lung adenocarcin...

por Yaning Yang, Haiyan Xu, Li Ma, Lu Yang, Guangjian Yang, Shuyang Zhang, Xin Ai, Shucai Zhang, Yan Wang
Publicado 2021

Absorbing filter AN69 surface treatment in critically ill COVID-19 patients: a single-center experience

por Gang Chen, Jie Ma, Peng Xia, Yan Hu, Zhengyin Liu, Xiang Zhou, Taisheng Li, Xiaowei Yan, Limeng Chen, Xuemei Li, Yan Qin, Shuyang Zhang
Publicado 2021